These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6221201)

  • 1. Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases.
    Jiang D; Reches A; Fahn S
    Neurology; 1983 Jun; 33(6):793-6. PubMed ID: 6221201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.
    Olney JW; Zorumski CF; Stewart GR; Price MT; Wang GJ; Labruyere J
    Exp Neurol; 1990 Jun; 108(3):269-72. PubMed ID: 1972067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
    Rodgers KJ; Hume PM; Morris JG; Dean RT
    J Neurochem; 2006 Aug; 98(4):1061-7. PubMed ID: 16771833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells.
    Floud A; Fahn S
    Biochim Biophys Acta; 1981 Jul; 645(2):165-9. PubMed ID: 7272286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in Parkinson's disease and Huntington's chorea.
    Barbeau A
    Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of transport systems for the transfer of 3,4-L-dihydroxyphenylalanine into slices of rat cerebral cortex.
    Garcia-Sancho FJ; Herreros B
    Biochim Biophys Acta; 1975 Nov; 406(4):538-52. PubMed ID: 1182175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
    Kostrzewa RM; Kostrzewa JP; Brus R
    Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules.
    Soares-da-Silva P; Fernandes MH; Pinto-do-O PC
    Br J Pharmacol; 1994 Jun; 112(2):611-5. PubMed ID: 8075877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetaminophen sulfation in patients with Parkinson's disease or Huntington's disease is not impaired.
    Roos RA; Steenvoorden JM; Mulder GJ; Van Kempen GM
    Neurology; 1993 Jul; 43(7):1373-6. PubMed ID: 8327140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET.
    Boecker H; Ceballos-Baumann A; Bartenstein P; Weindl A; Siebner HR; Fassbender T; Munz F; Schwaiger M; Conrad B
    Brain; 1999 Sep; 122 ( Pt 9)():1651-65. PubMed ID: 10468505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of amino acid transport in horse erythrocytes: a detailed kinetic analysis of inherited transport variation.
    Fincham DA; Mason DK; Paterson JY; Young JD
    J Physiol; 1987 Aug; 389():385-409. PubMed ID: 3681732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
    Hague SM; Klaffke S; Bandmann O
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection.
    Wade LA; Katzman R
    Am J Physiol; 1975 Feb; 228(2):352-9. PubMed ID: 1119556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia.
    Agostino R; Berardelli A; Formica A; Accornero N; Manfredi M
    Brain; 1992 Oct; 115 ( Pt 5)():1481-95. PubMed ID: 1422799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apical and basolateral uptake and intracellular fate of dopamine precursor L-dopa in LLC-PK1 cells.
    Soares-Da-Silva P; Serrão MP; Vieira-Coelho MA
    Am J Physiol; 1998 Feb; 274(2):F243-51. PubMed ID: 9486218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
    Jahanshahi M; Brown RG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1169-77. PubMed ID: 8229028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.